Effect of captopril and aprotinin on inactive renin

The Journal of Clinical Endocrinology and Metabolism
J E SealeyS A Atlas

Abstract

Inactive renin (prorenin) was measured in plasma from untreated hypertensive patients after acute (60 min) administration of the angiotensin I converting enzyme inhibitor captopril, after 4 weeks of treatment with captopril, and after an acute infusion of the protease inhibitor aprotinin. Inactive renin was unchanged during acute captopril therapy despite a 4-fold increase in active renin. In contrast, after 4 weeks of treatment with captopril, inactive renin had increased 2-fold and active renin was also elevated, but to a greater degree (6-fold). Active renin was significantly suppressed by the aprotinin infusion, to about 25%, but the inactive plasma renin level was apparently unchanged. These studies demonstrate that the time course of the responses of active and inactive plasma renins are different; the inactive renin level seems to change more slowly than does active renin in response to the same stimulus. The results also show that a neutral serine protease inhibitor can rapidly reduce the circulating level of active renin. This observation is consistent with the possibility, but does not prove it, that a kallikrein-like enzyme normally activating prorenin was inhibited by aprotinin.

Citations

Oct 1, 1982·Klinische Wochenschrift·A OverlackM Higuchi
Jan 1, 1985·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·G M PatrassiF H Derkx
Mar 27, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·J E Roulston, C G Wathen
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·M KawamuraM Ikeda
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·K ChimoriK Miura
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·K OgawaC Kawai
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·F ManteroA Girolami
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·A SalvettiF Turini
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·K OgawaC Kawai
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·K OgawaA Hara
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·I M McKenzieJ K McKenzie
May 1, 1994·Clinical and Experimental Hypertension : CHE·R BaldonciniF Balsano
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·E Haber, W Carlson
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·A MorgantiA Zanchetti
Aug 1, 1992·Kidney International·H R Brunner
Jun 28, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Lena R Thurner, Klaus Höcherl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.